Metabolic Signature of Insulin Resistance and Risk of Alzheimer’s Disease
We have identified a blood-based metabolic signature that reflects IR and may enhance our understanding of the biological mechanisms through which IR affects AD-dementia.
Authors
- Domènec Puig (ORCID: https://orcid.org/0000-0002-0562-4205)
- Marta Marquié (ORCID: https://orcid.org/0000-0002-0660-0950)
- Agustı́n Ruiz (ORCID: https://orcid.org/0000-0003-2633-2495)
- Laia Gutiérrez-Tordera (ORCID: https://orcid.org/0000-0003-4427-6845)
- Hamza Mostafa (ORCID: https://orcid.org/0000-0003-4319-9542)
- Jaume Folch (ORCID: https://orcid.org/0000-0002-5051-8858)
- Christopher Papandreou (ORCID: https://orcid.org/0000-0002-6803-507X)
- Merçé Boada (ORCID: https://orcid.org/0000-0003-2617-3009)
- Melina Rojas (ORCID: https://orcid.org/0000-0002-4743-5613)
- Mònica Bulló (ORCID: https://orcid.org/0000-0002-0218-7046)
- Pablo García‐González (ORCID: https://orcid.org/0000-0003-0125-5403)
- Hatem A. Rashwan (ORCID: https://orcid.org/0000-0001-5421-1637)
- Mercedes Atienza (ORCID: https://orcid.org/0000-0002-6760-1252)
- Nil Novau-Ferré
- Muhammad Mursil (ORCID: https://orcid.org/0000-0002-6986-8188)
- Javier Mateu-Fabregat (ORCID: https://orcid.org/0009-0002-1628-0118)
- Laura Panisello (ORCID: https://orcid.org/0009-0006-2943-3450)
- José Luis Cantero (ORCID: https://orcid.org/0000-0002-2628-7076)
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- Universitat Internacional de Catalunya (ES)
- Institut de Recerca Biomèdica Catalunya Sud (ES)
- Institute for Neurodegenerative Disorders (US)
- Universitat Rovira i Virgili (ES)
- Universidad Pablo de Olavide (ES)
Publication Details
- Journal
- The Journals of Gerontology Series A
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1093/gerona/glae283
- Citations
- 5
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 1.79
Funders
- EU Joint Programme – Neurodegenerative Disease Research
- European Federation of Pharmaceutical Industries and Associations
- European Commission
- Generalitat de Catalunya
- Ministerio de Economía y Competitividad
- Institució Catalana de Recerca i Estudis Avançats
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III
- European Regional Development Fund